Highly diastereoselective approach to novel tetrahydrofuran-fused indolizidinols: a one-step formation of three contiguous stereocenters

Tetrahedron Asymmetry

Volumn 19, Issue 4, 2008, Pages 467-475

  Šafář, Peter ^a   Žúžiová, Jozefína ^a   Bobošíková, Mária ^a   Marchalín, Štefan ^a   Prónayová, Nadežda ^a   Dalla, Vincent ^b   Daïch, Adam ^b  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b UNIVERSITÉ DU HAVRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; FURAN DERIVATIVE; INDOLIZINE DERIVATIVE; TETRAHYDROFURAN;

ARTICLE; CATALYSIS; CATALYST; HYDROGENATION; PRIORITY JOURNAL; STEREOCHEMISTRY; SYNTHESIS;

EID: 39949083371     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2008.01.013     Document Type: Article

References (53)

1. Das P.C., Roberts J.D., White S.L., and Olden K. Oncol. Res. 7 (1995) 425
2. Goss P.E., Reid C.L., Bailey D., and Dennis J.W. Clin. Cancer Res. 3 (1997) 1077
3. Wang S., Panter K.E., Holyoak G.R., Molyneux R.J., Lui G., Evans R.C., and Bunch T.D. Anim. Reprod. Sci. 56 (1999) 19
4. Michael J.P. Nat. Prod. Rep. 17 (2000) 579
5. Michael J.P. Nat. Prod. Rep. 20 (2003) 458
6. Michael J.P. Nat. Prod. Rep. 22 (2005) 603 and other references cited therein
7. Asano N. Curr. Top. Med. Chem. 3 (2003) 471
8. Cipolla L., Ferla B.L., and Nicotra F. Curr. Top. Med. Chem. 3 (2003) 485
9. Greimel P., Spreitz J., Stütz A.E., and Wrodnigg T.M. Curr. Top. Med. Chem. 3 (2003) 513
10. Schramm V.L., and Tyler P.C. Curr. Top. Med. Chem. 3 (2003) 525
11. Compain P., and Martin O.R. Curr. Top. Med. Chem. 3 (2003) 541
12. Butters T.D., Dwek R.A., and Platt F.M. Curr. Top. Med. Chem. 3 (2003) 561
13. Kino I., Inamura N., Klakahara K., Kiyoto S., Goto T., Terano H., and Kohsaka M. J. Antibiot. 38 (1985) 936
14. Cenci di Bello I., Fleet G.W.J., Namgoong S.K., Tadano K.I., and Winchester B.G. Biochem. J. 259 (1989) 855
15. Elbein A.D. FASEB J. 5 (1991) 3055
16. Goss P.E., Baker M.A., Carver J.P., and Dennis J.W. Clin. Cancer Res. 1 (1995) 935
17. Elbein A.D., and Molyneux R.J. In: Stütz A.E. (Ed). Iminosugars as Glycosidase Inhibitors (1999), Wiley-VCH, Weinheim pp 216-251
18. Legler G. Adv. Carbohydr. Chem. Biochem. 48 (1999) 319
19. Arnone A., Broggini G., Passarella D., Terraneo A., and Zecchi G. J. Org. Chem. 63 (1998) 9279
20. Harris T.M., Harris C.M., Hill J.E., Ungemach F.S., Broquist H.P., and Wickwire B.M. J. Org. Chem. 52 (1987) 3094
21. Harris C.M., Campbell B.C., Molyneux R.J., and Harris T.M. Tetrahedron Lett. 29 (1988) 4815
22. Pastuszak I., Molyneux R.J., James L.F., and Elbein A.D. Biochemistry 29 (1990) 1886
23. Na H.S., Choi J., Yu J., Shin K.J., Yoo K.H., Kim D.J., and Park S.W. Heterocycles 48 (1998) 2365
24. Pearson W.H., and Guo L. Tetrahedron Lett. 42 (2001) 8267
25. Pearson W.H., and Hembre E.J. Tetrahedron Lett. 42 (2001) 8273
26. For another recent attractive route to enantiopure carbon and hetero-7-substituted swainsonine analogues, see:. Tinarelli A., and Paolucci C. J. Org. Chem. 71 (2006) 6630
27. Fujita T., Nagasawa H., Uto Y., Hashimoto T., Asakawa Y., and Hori H. Org. Lett. 6 (2004) 827
28. Marchalín S., Kadlečíková K., Bar N., and Decroix B. Synth. Commun. 28 (1998) 3619
29. Szemes F., Marchalín S., Bar N., and Decroix B. J. Heterocycl. Chem. 35 (1998) 1371
30. Marchalín S., Szemes F., Bar N., and Decroix B. Heterocycles 50 (1999) 445
31. Szemes F., Kadlečíková K., Marchalín S., Bobošíková M., Dalla V., and Daïch A. Tetrahedron: Asymmetry 15 (2004) 1763
32. For a few known other strategies toward indolizidines using (S)-glutamic acid, see:. Ikota N., and Hanaki A. Chem. Pharm. Bull. 35 (1987) 2140
33. Ikota N. Chem. Pharm. Bull. 38 (1990) 2712
34. Keck G.E., and Romer D.R. J. Org. Chem. 58 (1993) 6083
35. Zhou W.-S., Xie W.-G., Lu Z.-H., and Pan X.-F. Tetrahedron Lett. 36 (1995) 1291
36. Gage J.L., and Branchaud B.P. Tetrahedron Lett. 38 (1997) 7007
37. Kadlečíková K., Dalla V., Marchalín S., Decroix B., and Baran P. Tetrahedron 61 (2005) 4743
38. Marchalín S., Žúžiová J., Kadlečiková K., Safar P., Baran P., Dalla V., and Daïch A. Tetrahedron Lett. 48 (2007) 697
39. Gypser A., and Sharf H.-D. Synthesis (1996) 349
40. White J.D., Hrnciar P., and Stappenbeck F. J. Org. Chem. 62 (1997) 5250
41. Albert M., De Souza D., Feiertag P., and Hönig H. Org. Lett. 4 (2002) 3251
42. Kaiser S., Smidt S.P., and Pfaltz A. Angew. Chem., Int. Ed. 45 (2006) 5194
43. Feiertag P., Albert M., Nettekoven U., and Spindler F. Org. Lett. 8 (2006) 4133
44. Šcorc L., Vrábel V., Kožišek J., Marchalín S., and Žúžiová J. Acta Crystallogr. E 63 (2007) o1452
45. Liu C.-T., Chang C.-H., and Chou T.-L. J. Heterocycl. Chem. 21 (1984) 129
46. This diagnostic is limited to the experiments catalyzed with Ra-Ni.
47. The following results were obtained: iPrOH 4/5: 57/43, THF 4/5: 49/51, AcOEt 4/5: 52/48.
48. For selectivity-enhancing effect of an ADmix additive in the catalytic hydrogenation of heteroaromatic cycles, see:. Kuwano R., Sato K., Kurokawa T., Karube D., and Ito Y. J. Am. Chem. Soc. 122 (2000) 7614
49. Kuwano R., Kaneda K., Ito T., Sato K., Kurokawa T., and Ito Y. Org. Lett. 6 (2004) 2213
50. MaGee D.I., Lee M.L., and Decken A. J. Org. Chem. 64 (1999) 2549
51. Ranade V.S., Consiglio G., and Prins R. J. Org. Chem. 64 (1999) 8862
52. Ranade V.S., Consiglio G., and Prins R. J. Org. Chem. 65 (2000) 1132
53. Rasmussen M.O., Delair P., and Greene A.E. J. Org. Chem. 66 (2001) 5438